WEBSITE BSE:533210 NSE: KRITI NUTRI Inc. Year: 1996 Industry: Edible Oil My Bucket: Add Stock
Last updated: 15:24
No Notes Added Yet
Kriti Nutrients Ltd is engaged in soya seed extraction, and manufacturing and selling of cooking oil under its very own brand KRITI. The Company's number one products encompass soya lecithin flakes and flour, and soya crude oil/subtle oil. It has a manufacturing setup, which incorporates solvent extraction plants, vegetable oil refinery, lecithin plant, effluent remedy plant, fluidized bed boilers and an in-house tin and jar manufacturing facility. It uses non-genetically modified organism (GMO) soyabean seeds with a nutrient content to manufac...Read More
Kriti Nutrients Ltd is engaged in soya seed extraction, and manufacturing and selling of cooking oil under its very own brand KRITI. The Company's number one products encompass soya lecithin flakes and flour, and soya crude oil/subtle oil. It has a manufacturing setup, which incorporates solvent extraction plants, vegetable oil refinery, lecithin plant, effluent remedy plant, fluidized bed boilers and an in-house tin and jar manufacturing facility. It uses non-genetically modified organism (GMO) soyabean seeds with a nutrient content to manufacture a product variety, which incorporates refined soyabean oil, Superhypro meal, Defatted soya flakes and lecithin used for human consumption, cattle feed, poultry, aquaculture, confectionary, dairy product, business packages and pharmaceutical arrangements. Its merchandise additionally encompass soymeal and soya grits. The Company is also engaged in buying and selling sunflower oil. Its soya plant is positioned at Dewas, with a place of approximately 60,520 sq meters. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹441 Cr.
Stock P/E 11.9
P/B 1.9
Current Price ₹88
Book Value ₹ 45.7
Face Value 1
52W High ₹125
Dividend Yield 0%
52W Low ₹ 52.3
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 172 | 188 | 174 | 173 | 200 | 229 | 213 | 224 | 255 |
| Other Income | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Total Income | 173 | 189 | 175 | 175 | 202 | 231 | 215 | 226 | 257 |
| Total Expenditure | 159 | 169 | 161 | 162 | 194 | 218 | 202 | 213 | 246 |
| Operating Profit | 14 | 20 | 14 | 14 | 8 | 13 | 14 | 13 | 11 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 12 | 19 | 13 | 12 | 6 | 12 | 12 | 12 | 9 |
| Provision for Tax | 4 | 5 | 3 | 4 | 1 | 3 | 3 | 3 | 3 |
| Profit After Tax | 9 | 14 | 10 | 8 | 5 | 9 | 9 | 9 | 6 |
| Adjustments | 0 | 0 | -0 | 0 | -0 | 0 | -0 | -0 | 0 |
| Profit After Adjustments | 9 | 14 | 10 | 8 | 5 | 9 | 9 | 9 | 6 |
| Adjusted Earnings Per Share | 1.7 | 2.8 | 1.9 | 1.6 | 1 | 1.9 | 1.8 | 1.8 | 1.3 |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|
| Net Sales | 684 | 734 | 921 |
| Other Income | 4 | 8 | 8 |
| Total Income | 689 | 742 | 929 |
| Total Expenditure | 622 | 686 | 879 |
| Operating Profit | 67 | 56 | 51 |
| Interest | 1 | 1 | 0 |
| Depreciation | 5 | 5 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 |
| Profit Before Tax | 61 | 50 | 45 |
| Provision for Tax | 15 | 13 | 12 |
| Profit After Tax | 45 | 37 | 33 |
| Adjustments | 0 | -0 | 0 |
| Profit After Adjustments | 45 | 37 | 33 |
| Adjusted Earnings Per Share | 9 | 7.4 | 6.8 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 7% | 0% | 0% | 0% |
| Operating Profit CAGR | -16% | 0% | 0% | 0% |
| PAT CAGR | -18% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -18% | 23% | 12% | 16% |
| ROE Average | 19% | 22% | 22% | 22% |
| ROCE Average | 25% | 29% | 29% | 29% |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 |
|---|---|---|
| Shareholder's Funds | 176 | 212 |
| Minority's Interest | 0 | 0 |
| Borrowings | 0 | 0 |
| Other Non-Current Liabilities | 7 | 7 |
| Total Current Liabilities | 26 | 19 |
| Total Liabilities | 209 | 238 |
| Fixed Assets | 58 | 58 |
| Other Non-Current Assets | 37 | 85 |
| Total Current Assets | 114 | 95 |
| Total Assets | 209 | 238 |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 |
|---|---|---|
| Opening Cash & Cash Equivalents | 19 | 9 |
| Cash Flow from Operating Activities | 50 | 32 |
| Cash Flow from Investing Activities | -29 | -29 |
| Cash Flow from Financing Activities | -30 | -11 |
| Net Cash Inflow / Outflow | -10 | -8 |
| Closing Cash & Cash Equivalent | 9 | 2 |
| # | Mar 2024 | Mar 2025 |
|---|---|---|
| Earnings Per Share (Rs) | 9.04 | 7.38 |
| CEPS(Rs) | 9.98 | 8.48 |
| DPS(Rs) | 0.3 | 0.3 |
| Book NAV/Share(Rs) | 35.22 | 42.28 |
| Core EBITDA Margin(%) | 9.09 | 6.54 |
| EBIT Margin(%) | 9.06 | 6.86 |
| Pre Tax Margin(%) | 8.85 | 6.78 |
| PAT Margin (%) | 6.62 | 5.04 |
| Cash Profit Margin (%) | 7.3 | 5.78 |
| ROA(%) | 21.67 | 16.57 |
| ROE(%) | 25.66 | 19.07 |
| ROCE(%) | 33.23 | 25.2 |
| Receivable days | 11.03 | 7.37 |
| Inventory Days | 25.54 | 21.53 |
| Payable days | 3.1 | 2.91 |
| PER(x) | 10.21 | 13.41 |
| Price/Book(x) | 2.62 | 2.34 |
| Dividend Yield(%) | 0.33 | 0.3 |
| EV/Net Sales(x) | 0.66 | 0.66 |
| EV/Core EBITDA(x) | 6.75 | 8.66 |
| Net Sales Growth(%) | 0 | 7.3 |
| EBIT Growth(%) | 0 | -18.76 |
| PAT Growth(%) | 0 | -18.25 |
| EPS Growth(%) | 0 | -18.31 |
| Debt/Equity(x) | 0.06 | 0.01 |
| Current Ratio(x) | 4.39 | 4.91 |
| Quick Ratio(x) | 2.55 | 2.91 |
| Interest Cover(x) | 44.58 | 87.9 |
| Total Debt/Mcap(x) | 0.02 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 66.68 | 66.68 | 66.68 | 66.68 | 66.68 | 66.68 | 66.68 | 66.68 | 66.68 | 66.68 |
| FII | 0 | 0 | 0.02 | 0.03 | 0.04 | 0.03 | 0.01 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 |
| Public | 33.31 | 33.31 | 33.29 | 33.29 | 33.27 | 33.28 | 33.3 | 33.31 | 33.31 | 33.3 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 3.34 | 3.34 | 3.34 | 3.34 | 3.34 | 3.34 | 3.34 | 3.34 | 3.34 | 3.34 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 1.67 | 1.67 | 1.67 | 1.67 | 1.67 | 1.67 | 1.67 | 1.67 | 1.67 | 1.67 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5.01 | 5.01 | 5.01 | 5.01 | 5.01 | 5.01 | 5.01 | 5.01 | 5.01 | 5.01 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
